Related references
Note: Only part of the references are listed.Thiadiazoles as new inhibitors of diacylglycerol acyltransferase type 1
Patrick Mougenot et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Design and synthesis of potent carboxylic acid DGAT1 inhibitors with high cell permeability
Ustav Bali et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
The use of stable isotope-labeled glycerol and oleic acid to differentiate the hepatic functions of DGAT1 and-2
Jenson Qi et al.
JOURNAL OF LIPID RESEARCH (2012)
Evolutionary view of acyl-CoA diacylglycerol acyltransferase (DGAT), a key enzyme in neutral lipid biosynthesis
Andreia C. Turchetto-Zolet et al.
BMC EVOLUTIONARY BIOLOGY (2011)
Targeting Acyl-CoA:Diacylglycerol Acyltransferase 1 (DGAT1) with Small Molecule Inhibitors for the Treatment of Metabolic Diseases
Jingsong Cao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Discovery of Orally Active Carboxylic Acid Derivatives of 2-Phenyl-5-trifluoromethyloxazole-4-carboxamide as Potent Diacylglycerol Acyltransferase-1 Inhibitors for the Potential Treatment of Obesity and Diabetes
Yimin Qian et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Discovery of PF-04620110, a Potent, Selective, and Orally Bioavailable Inhibitor of DGAT-1
Robert L. Dow et al.
ACS MEDICINAL CHEMISTRY LETTERS (2011)
Novel acyl coenzyme A (CoA): Diacylglycerol acyltransferase-1 inhibitors: Synthesis and biological activities of diacylethylenediamine derivatives
Yoshihisa Nakada et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Novel Acyl Coenzyme A: Diacylglycerol Acyltransferase 1 Inhibitors-Synthesis and Biological Activities of N-(Substituted heteroaryl)-4-(substituted phenyl)-4-oxobutanamides
Yoshihisa Nakada et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2010)
Inhibitors of diacylglycerol acyltransferase: a review of 2008 patents
Andrew J. King et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2010)
Involvement and mechanism of DGAT2 upregulation in the pathogenesis of alcoholic fatty liver disease
Zhigang Wang et al.
JOURNAL OF LIPID RESEARCH (2010)
Discovery of a Potent, Selective, and Orally Efficacious Pyrimidinooxazinyl Bicyclooctaneacetic Acid Diacylglycerol Acyltransferase-1 Inhibitor
Alan M. Birch et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
DGAT enzymes and triacylglycerol biosynthesis
Chi-Liang Eric Yen et al.
JOURNAL OF LIPID RESEARCH (2008)
Validation of diacyl glycerolacyltransferase I as a novel target for the treatment of obesity and dyslipidemia using a potent and selective small molecule inhibitor
Gang Zhao et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis
Kanji Yamaguchi et al.
HEPATOLOGY (2007)
In vitro inhibition of diacylglycerol acyltransferase by prenylflavonoids from Sophora flavescens
MY Chung et al.
PLANTA MEDICA (2004)
Fatty acids, triglycerides, and glucose metabolism: recent insights from knockout mice
HC Chen et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2002)
DGAT and triglyceride synthesis: A new target for obesity treatment?
HC Chen et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2000)
Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat
SJ Smith et al.
NATURE GENETICS (2000)
Share Paper
